Extramural venous invasion: a novel magnetic resonance imaging biomarker for adverse pathology in bladder cancer.

ABSTRACT: Extramural venous invasion (EMVI) recognized on magnetic resonance imaging (MRI) is an unequivocal biomarker for detecting adverse outcomes in rectal cancer: however it has not yet been explored in the area of bladder cancer. In this study, we assessed the feasibility of identifying EMVI findings on MRI in patients with bladder cancer and its avail in identifying adverse pathology. In this single-institution retrospective study, the MRI findings inclusive of EMVI was described in patients with bladder cancer that had available imaging between January 2018 and June 2020. Patient demographic and clinical information were retrieved from our electronic medical records system. Histopathologic features frequently associated with poor outcomes including lymphovascular invasion (LVI), variant hist

SUBMITTER: Bazargani S 

PROVIDER: S-EPMC10165227 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature